文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

影响偶发性甲状腺微小乳头状癌患者预后的因素。

Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma.

作者信息

Mantinan Beatriz, Rego-Iraeta Antonia, Larrañaga Alejandra, Fluiters Enrique, Sánchez-Sobrino Paula, Garcia-Mayor Ricardo V

机构信息

Endocrine, Diabetes, Nutrition and Metabolism Department, University Hospital of Vigo, P.O. Box 1691, Plaza de Compostela 3, 36201 Vigo, Spain.

出版信息

J Thyroid Res. 2012;2012:469397. doi: 10.1155/2012/469397. Epub 2012 Oct 2.


DOI:10.1155/2012/469397
PMID:23091775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3469245/
Abstract

Objective. To analyze some factors that could influence the outcome of patients with PTMC. Material and Methods. This is a longitudinal observational study. All patients diagnosed and treated for papillary thyroid microcarcinoma at the University Hospital of Vigo, between January 1994 and December 2003, were included in the present study. Demographic characteristics, tumour characteristics, TNM stage, rate of recurrence, and treatment with (131)I were the study variables. Results. Ninety-one patients (75 females) with an average age of 47.7 ± 13.4 years, range 19-81, were studied. Initial tumour staging was T1 in 90 patients and T4a in 1 case. Initial lymph node involvement was present in 4 cases (4.4%). We only found one case with distant metastases at diagnosis. Postsurgical evaluation of thyroid specimens revealed that 28 (30.7%) tumours were multifocal. The average size of the tumour was 0.44 ± 0.25 cm, range 0.1-1. Univariate analysis reveals a statistically significant association between tumour multifocality and postsurgical (131)I therapy with the recurrence rate. In the multivariate analysis only multifocality (P = 0.037, HR 5.7) was a significant risk factor for the recurrence rate. Conclusions. Our results indicate that tumour multifocality is an independent predictor of relapse but neither the tumour size nor postsurgical (131)I therapy.

摘要

目的。分析一些可能影响甲状腺微小乳头状癌(PTMC)患者预后的因素。材料与方法。这是一项纵向观察性研究。纳入了1994年1月至2003年12月期间在维戈大学医院诊断并接受治疗的所有甲状腺微小乳头状癌患者。人口统计学特征、肿瘤特征、TNM分期、复发率以及¹³¹I治疗情况为研究变量。结果。共研究了91例患者(75例女性),平均年龄为47.7±13.4岁,年龄范围19 - 81岁。初始肿瘤分期为T1期的患者有90例,T4a期1例。初始有4例(4.4%)出现淋巴结受累。诊断时仅发现1例有远处转移。对甲状腺标本的术后评估显示,28例(30.7%)肿瘤为多灶性。肿瘤平均大小为0.44±0.25 cm,范围0.1 - 1 cm。单因素分析显示肿瘤多灶性及术后¹³¹I治疗与复发率之间存在统计学显著关联。多因素分析中,只有多灶性(P = 0.037,HR 5.7)是复发率的显著危险因素。结论。我们的结果表明,肿瘤多灶性是复发的独立预测因素,而肿瘤大小及术后¹³¹I治疗并非如此。

相似文献

[1]
Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma.

J Thyroid Res. 2012

[2]
Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.

Bull Cancer. 2017-6

[3]
Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.

Exp Ther Med. 2020-12

[4]
Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.

Eur J Clin Invest. 2011-12-14

[5]
Risk factors associated with intrathyroid extension of thyroid microcarcinomas.

Langenbecks Arch Surg. 2018-8

[6]
Significance of multifocality in papillary thyroid carcinoma.

Eur J Surg Oncol. 2020-10

[7]
Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.

Head Neck. 2014-4

[8]
Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases.

Eur Ann Otorhinolaryngol Head Neck Dis. 2012-4-3

[9]
Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.

J Surg Res. 2018-1

[10]
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.

Minerva Endocrinol. 2013-9

引用本文的文献

[1]
Geriatric Importance of Histopathological Parameters Evaluated in Thyroidectomy Specimens: A Single Center Retrospective Analysis.

J Pers Med. 2024-1-15

[2]
Prevalence and Predictors of Malignancy in Contralateral Thyroid Lobe in Patients Undergoing Completion Thyroidectomy.

Indian J Otolaryngol Head Neck Surg. 2022-10

[3]
Diagnostic Efficacy of Ultrasound, Cytology, and BRAF Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma.

Front Oncol. 2022-1-3

[4]
Prevalence and predictor for malignancy of contralateral thyroid nodules in patients with unilateral PTMC: a systematic review and meta-analysis.

Endocr Connect. 2021-6-21

[5]
Relationships between clinicopathological prognostic factors in papillary thyroid microcarcinoma: a refined analysis based on 428 cases.

Int J Clin Exp Pathol. 2017-8-1

[6]
Clinical-pathological Characteristics and Prognostic Factors for Papillary Thyroid Microcarcinoma in the Elderly.

J Cancer. 2018-1-1

[7]
Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.

Updates Surg. 2018-3

[8]
A meta-analysis on the effect of operation modes on the recurrence of papillary thyroid microcarcinoma.

Oncotarget. 2017-1-24

[9]
Incidental Papillary Thyroid Microcarcinoma in an Endemic Goiter Area.

J Thyroid Res. 2016

[10]
Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.

Endocr Pathol. 2015-12

本文引用的文献

[1]
Approach to the patient with incidental papillary microcarcinoma.

J Clin Endocrinol Metab. 2010-8

[2]
An observational trial for papillary thyroid microcarcinoma in Japanese patients.

World J Surg. 2010-1

[3]
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Thyroid. 2009-11

[4]
Recurrence after treatment of micropapillary thyroid cancer.

Thyroid. 2009-10

[5]
Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma.

Thyroid. 2009-4

[6]
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.

Surgery. 2008-12

[7]
Papillary thyroid microcarcinoma: prognostic factors and treatment.

J Surg Oncol. 2008-3-1

[8]
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid.

Nat Clin Pract Endocrinol Metab. 2007-3

[9]
Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease.

J Postgrad Med. 2007

[10]
Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series.

Endocr Pathol. 2006

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索